+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Nanotechnology in Drug Delivery: Global Strategic Business Report

  • PDF Icon

    Report

  • 272 Pages
  • March 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 2769238

Global Nanotechnology in Drug Delivery Market to Reach $122.7 Billion by 2030

The global market for Nanotechnology in Drug Delivery estimated at US$68.5 Billion in the year 2022, is projected to reach a revised size of US$122.7 Billion by 2030, growing at a CAGR of 7.6% over the analysis period 2022-2030. Nanoparticles, one of the segments analyzed in the report, is projected to record 7.8% CAGR and reach US$35.6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Liposomes segment is readjusted to a revised 7.9% CAGR for the next 8-year period.

The U.S. Market is Estimated at $18.5 Billion, While China is Forecast to Grow at 12.5% CAGR

The Nanotechnology in Drug Delivery market in the U.S. is estimated at US$18.5 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$30.6 Billion by the year 2030 trailing a CAGR of 12.5% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.9% and 6.5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4% CAGR.

Select Competitors (Total 36 Featured) -

  • AbbVie Inc.
  • Aquanova AG
  • BlueWillow Biologics
  • Camurus AB
  • Celgene, Inc.
  • Ceramisphere Health Pty Limited
  • Cristal Therapeutics
  • CYTIMMUNE SCIENCES, Inc.
  • EnColl Corporation
  • EyePoint Pharmaceuticals
  • Lena Nanoceutics Ltd.
  • Nanobiotix
  • NanoCarrier Co., Ltd.
  • NanOlogy LLC
  • Nanospectra Biosciences, Inc.
  • Parvus Therapeutics Inc.
  • Selecta Biosciences
  • Starpharma Holdings Limited
  • Taiwan Liposome Co.,
  • Tarveda Therapeutics

What's New?

  • Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and Research Platform
  • Complimentary updates for one year

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Nanotechnology, A Critical Part of Healthcare Reform
  • Recent Market Activity
  • Nanomedicine, Revolutionizing the Basics of Medicine
  • A Peek Into the Evolving Role of Nanoparticles in Nanomedicine
  • Nanocrystals Continue to Gain Momentum as Alternatives to Traditional Nanocarriers
  • Nanocarriers Enable Targeted Drug Delivery Systems to Improve Therapeutic Outcomes
  • Advanced Liposomes Enable Low Soluble Drugs to Achieve Targeted Delivery
  • Multifunctional Dendrimers Present an Ideal Structure for Targeted Drug Delivery
  • High Drug Loading Capacity of PAMAM Dendrimers Bodes Well for Targeted Drug Delivery Systems
  • Nanotechnology-Based Strategies for siRNA Grows in Popularity
  • NEM Devices as Drug Delivery Vehicles
  • Nanotechnology - In Pursuit of Co-Delivery of Drugs
  • Nanoemulsions Begin to Make a Mark
  • Nanotechnology Finds Increasing Role in Fighting Infectious Diseases
  • List of Select Nanotechnology-based Antimicrobial Drugs in Clinical Use
  • Nanotechnology Opening New Avenues in Antiretroviral Therapy
  • Demonstrated Activity of Select Nanotechnology- Delivered Antiretroviral Therapies
  • Nanotechnology in Delivery of CNS Therapeutics
  • Market Outlook
  • Nanotechnology in Drug Delivery - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
  • AbbVie Inc. (USA)
  • Aquanova AG (Germany)
  • BlueWillow Biologics (USA)
  • Camurus AB (Sweden)
  • Celgene, Inc. (Canada)
  • Ceramisphere Health Pty Limited (Australia)
  • Cristal Therapeutics (The Netherlands)
  • CYTIMMUNE SCIENCES, INC. (Italy)
  • EnColl Corporation (USA)
  • EyePoint Pharmaceuticals (USA)
  • Lena Nanoceutics Ltd. (UK)
  • NanOlogy LLC (USA)
  • NanoCarrier Co., Ltd. (Japan)
  • Nanobiotix (France)
  • Nanospectra Biosciences, Inc (USA)
  • Parvus Therapeutics Inc. (USA)
  • Selecta Biosciences (USA)
  • Starpharma Holdings Limited (Australia)
  • Taiwan Liposome Co. (Taiwan)
  • Tarveda Therapeutics (USA)
3. MARKET TRENDS & DRIVERS
  • Growing Need for Alternative Approaches to Conventional Chemotherapy Creates Opportunities for Nanoparticles
  • Stimuli Responsive Polymeric Micelles Promise Enhanced Therapeutic Effect for Hydrophobic Anticancer Drugs
  • Inorganic Nanocarriers Facilitate High Payload Capacity and Co-Delivery Platforms for MDR Cancer Therapy
  • Solid Lipid Nanoparticles Provide Increased Physical Stability in Targeted Drug Delivery
  • Pulmonary Delivery of Nanoparticle-Based Drugs Receives Increased Interest
  • Inhalable Liposome Formulations Attract Research Interest in Pulmonary Delivery
  • SLNs in Pulmonary Delivery of Drugs
  • Market Challenges
  • Increasing Environmental and Health Concerns
  • Limited Success and Scaling Up Issues Pose a Major Hurdle to Further Advancement
  • Higher Concentration of Research in Academia limits Commercialization
  • Collaborations Assume Importance
  • Nanomedicine Regulation
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 2: World 8-Year Perspective for Nanotechnology in Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2023 & 2030
  • Table 3: World Recent Past, Current & Future Analysis for Nanocrystals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 4: World 8-Year Perspective for Nanocrystals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
  • Table 5: World Recent Past, Current & Future Analysis for Nanoparticles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 6: World 8-Year Perspective for Nanoparticles by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Liposomes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 8: World 8-Year Perspective for Liposomes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
  • Table 9: World Recent Past, Current & Future Analysis for Nano Emulsions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 10: World 8-Year Perspective for Nano Emulsions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
  • Table 11: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 12: World 8-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 14: World 8-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
  • Table 15: World Recent Past, Current & Future Analysis for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 16: World 8-Year Perspective for Cardiovascular by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
  • Table 17: World Recent Past, Current & Future Analysis for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 18: World 8-Year Perspective for Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
  • Table 19: World Recent Past, Current & Future Analysis for Anti-Inflammatory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 20: World 8-Year Perspective for Anti-Inflammatory by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
  • Table 21: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 22: World 8-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
  • Table 23: World Nanotechnology in Drug Delivery Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
  • Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
  • Table 24: USA Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 25: USA 8-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2023 & 2030
  • Table 26: USA Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 27: USA 8-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2023 & 2030
CANADA
  • Table 28: Canada Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 29: Canada 8-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2023 & 2030
  • Table 30: Canada Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 31: Canada 8-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2023 & 2030
JAPAN
  • Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
  • Table 32: Japan Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 33: Japan 8-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2023 & 2030
  • Table 34: Japan Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 35: Japan 8-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2023 & 2030
CHINA
  • Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
  • Table 36: China Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 37: China 8-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2023 & 2030
  • Table 38: China Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 39: China 8-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2023 & 2030
EUROPE
  • Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
  • Table 40: Europe Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 41: Europe 8-Year Perspective for Nanotechnology in Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2023 & 2030
  • Table 42: Europe Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 43: Europe 8-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2023 & 2030
  • Table 44: Europe Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 45: Europe 8-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2023 & 2030
FRANCE
  • Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
  • Table 46: France Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 47: France 8-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2023 & 2030
  • Table 48: France Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 49: France 8-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2023 & 2030
GERMANY
  • Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
  • Table 50: Germany Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 51: Germany 8-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2023 & 2030
  • Table 52: Germany Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 53: Germany 8-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2023 & 2030
ITALY
  • Table 54: Italy Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 55: Italy 8-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2023 & 2030
  • Table 56: Italy Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 57: Italy 8-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2023 & 2030
UNITED KINGDOM
  • Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
  • Table 58: UK Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 59: UK 8-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2023 & 2030
  • Table 60: UK Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 61: UK 8-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2023 & 2030
SPAIN
  • Table 62: Spain Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 63: Spain 8-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2023 & 2030
  • Table 64: Spain Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 65: Spain 8-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2023 & 2030
RUSSIA
  • Table 66: Russia Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 67: Russia 8-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2023 & 2030
  • Table 68: Russia Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 69: Russia 8-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2023 & 2030
REST OF EUROPE
  • Table 70: Rest of Europe Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 71: Rest of Europe 8-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2023 & 2030
  • Table 72: Rest of Europe Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 73: Rest of Europe 8-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2023 & 2030
ASIA-PACIFIC
  • Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
  • Table 74: Asia-Pacific Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 75: Asia-Pacific 8-Year Perspective for Nanotechnology in Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2023 & 2030
  • Table 76: Asia-Pacific Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 77: Asia-Pacific 8-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2023 & 2030
  • Table 78: Asia-Pacific Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 79: Asia-Pacific 8-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2023 & 2030
AUSTRALIA
  • Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
INDIA
  • Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AbbVie Inc.
  • Aquanova AG
  • BlueWillow Biologics
  • Camurus AB
  • Celgene, Inc.
  • Ceramisphere Health Pty Limited
  • Cristal Therapeutics
  • CYTIMMUNE SCIENCES, Inc.
  • EnColl Corporation
  • EyePoint Pharmaceuticals
  • Lena Nanoceutics Ltd.
  • Nanobiotix
  • NanoCarrier Co., Ltd.
  • NanOlogy LLC
  • Nanospectra Biosciences, Inc.
  • Parvus Therapeutics Inc.
  • Selecta Biosciences
  • Starpharma Holdings Limited
  • Taiwan Liposome Co.,
  • Tarveda Therapeutics

Table Information